• Je něco špatně v tomto záznamu ?

Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group

B. Shen, G. Kochhar, U. Navaneethan, X. Liu, FA. Farraye, Y. Gonzalez-Lama, D. Bruining, DS. Pardi, M. Lukas, M. Bortlik, K. Wu, A. Sood, DA. Schwartz, WJ. Sandborn, Global Interventional Inflammatory Bowel Disease Group,

. 2019 ; 89 (2) : 215-237. [pub] 20181024

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc19028131

Interventional (or therapeutic) inflammatory bowel disease (IBD) endoscopy has an expanding role in the treatment of disease and surgical adverse events. Endoscopic therapy has been explored and used in the management of strictures, fistulas/abscesses, colitis-associated neoplasia, postsurgical acute or chronic leaks, and obstructions. The endoscopic therapeutic modalities include balloon dilation, stricturotomy, stent placement, fistulotomy, fistula injection and clipping, sinusotomy, EMR, and endoscopic submucosal dissection. With a better understanding of the disease course of IBD, improved long-term impact of medical therapy, and advances in endoscopic technology, we can foresee interventional IBD becoming an integrated part of the multidisciplinary approach to patients with complex IBD.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028131
003      
CZ-PrNML
005      
20190819112946.0
007      
ta
008      
190813s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.gie.2018.09.045 $2 doi
035    __
$a (PubMed)30365985
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Shen, Bo $u Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA. Electronic address: shenb@ccf.org.
245    10
$a Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group / $c B. Shen, G. Kochhar, U. Navaneethan, X. Liu, FA. Farraye, Y. Gonzalez-Lama, D. Bruining, DS. Pardi, M. Lukas, M. Bortlik, K. Wu, A. Sood, DA. Schwartz, WJ. Sandborn, Global Interventional Inflammatory Bowel Disease Group,
520    9_
$a Interventional (or therapeutic) inflammatory bowel disease (IBD) endoscopy has an expanding role in the treatment of disease and surgical adverse events. Endoscopic therapy has been explored and used in the management of strictures, fistulas/abscesses, colitis-associated neoplasia, postsurgical acute or chronic leaks, and obstructions. The endoscopic therapeutic modalities include balloon dilation, stricturotomy, stent placement, fistulotomy, fistula injection and clipping, sinusotomy, EMR, and endoscopic submucosal dissection. With a better understanding of the disease course of IBD, improved long-term impact of medical therapy, and advances in endoscopic technology, we can foresee interventional IBD becoming an integrated part of the multidisciplinary approach to patients with complex IBD.
650    _2
$a břišní absces $x etiologie $x chirurgie $7 D018784
650    _2
$a netěsnost anastomózy $x chirurgie $7 D057868
650    _2
$a biologické přípravky $x terapeutické užití $7 D001688
650    _2
$a kolorektální nádory $x etiologie $x chirurgie $7 D015179
650    _2
$a stenóza $7 D003251
650    _2
$a endoskopická mukózní resekce $7 D000069916
650    12
$a gastrointestinální endoskopie $7 D016099
650    _2
$a lidé $7 D006801
650    _2
$a idiopatické střevní záněty $x komplikace $x farmakoterapie $x chirurgie $7 D015212
650    _2
$a střevní píštěle $x etiologie $x chirurgie $7 D007412
650    _2
$a střevní obstrukce $x etiologie $x chirurgie $7 D007415
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Kochhar, Gursimran $u Division of Gastroenterology, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA.
700    1_
$a Navaneethan, Udayakumar $u Center for Interventional Endoscopy, Florida Hospital, Orlando, Florida, USA.
700    1_
$a Liu, Xiuli $u Department of Pathology and Laboratory Medicines, University of Florida Gainesville, Gainesville, Florida, USA.
700    1_
$a Farraye, Francis A $u Division of Gastroenterology, Boston Medical Center, Boston, Massachusetts, USA.
700    1_
$a Gonzalez-Lama, Yago $u Servicio de Gastroenterología y Hepatología, Hospital Universitario Puerta de Hierro, Madrid, Spain.
700    1_
$a Bruining, David $u Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
700    1_
$a Pardi, Darrell S $u Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
700    1_
$a Lukas, Martin $u Division of Gastroenerology, lékařská fakulta Univerzity Karlovy, Praha, Czech Republic.
700    1_
$a Bortlik, Martin $u Division of Gastroenerology, lékařská fakulta Univerzity Karlovy, Praha, Czech Republic.
700    1_
$a Wu, Kaicun $u Department of Gastroenterology, Xijin Hospital, Xi'an, China.
700    1_
$a Sood, Ajit $u Department of Gastroenterology, Dayanand Medical College, Ludhiana, India.
700    1_
$a Schwartz, David A $u Department of Gastroenterology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
700    1_
$a Sandborn, William J $u Division of Gastroenterology, University of California San Diego Medical Center, San Diego, California, USA.
710    2_
$a Global Interventional Inflammatory Bowel Disease Group
773    0_
$w MED00001881 $t Gastrointestinal endoscopy $x 1097-6779 $g Roč. 89, č. 2 (2019), s. 215-237
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30365985 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190819113220 $b ABA008
999    __
$a ok $b bmc $g 1433280 $s 1066591
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 89 $c 2 $d 215-237 $e 20181024 $i 1097-6779 $m Gastrointestinal endoscopy $n Gastrointest Endosc $x MED00001881
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Možnosti archivace